Common use of Development Data Clause in Contracts

Development Data. (a) Each Party shall solely own all data, records and reports generated by or on behalf of such Party, its Affiliates or Sublicensees (with respect to Oncoheroes), in the non-clinical and clinical Development of the Product (the “Product Data”); provided, that neither Party is deemed to conduct Development of the Product on behalf of the other Party. Notwithstanding any provision of this Agreement to the contrary, Product Data that a Party is required to deliver to the other Party under this Agreement shall be limited to Product Data that is (a) Controlled by such Party and (b) that is necessary or reasonably useful to support the Development, Regulatory Approval or Commercialization of the Products. (b) Each Party, shall, on a Calendar Quarterly basis and at no charge to the other Party, as permitted under Applicable Law (including GCP), provide the other Party with a summary of all Product Data not previously transferred under this Section 4.5. Allarity may disclose and provide copies of such Product Data Controlled by Oncoheroes to Allarity’s Affiliates and Third Party licensees that have agreed in writing to share development data with Allarity and Oncoheroes on terms substantially similar to the terms of this Section 4.5. Oncoheroes may disclose and provide copies of such Product Data Controlled by Allarity to Oncoheroes’ Affiliates and Sublicensees that have agreed in writing to share development data with Allarity and Oncoheroes on terms substantially similar to the terms of this Section 4.5.

Development Data. (a) Each Party shall solely own all data, records and reports generated by or on behalf of such Party, its Affiliates or Sublicensees (with respect to OncoheroesVerrica), in the non-clinical and clinical Development of the Product (the “Product Data”); provided, that neither Party is deemed to conduct Development of the Product on behalf of the other Party. Notwithstanding any provision of this Agreement to the contrary, Product Data that a Party is required to deliver to the other Party under this Agreement shall be limited to Product Data that is (a) Controlled by such Party and (b) that is necessary or reasonably useful to support the Development, Regulatory Approval or Commercialization of the Products. (b) Each Party, shall, on a Calendar Quarterly basis and at no charge to the other Party, as permitted under Applicable Law (including GCP), provide the other Party with a summary of all Product Data not previously transferred under this Section 4.50. Allarity Lytix may disclose and provide copies of such Product Data Controlled by Oncoheroes Verrica to AllarityLytix’s Affiliates and Third Party licensees that have agreed in writing to share development data with Allarity Lytix and Oncoheroes Verrica on terms substantially similar to the terms of this Section 4.5. Oncoheroes Verrica may disclose and provide copies of such Product Data Controlled by Allarity Lytix to Oncoheroes’ Verrica’s Affiliates and Sublicensees that have agreed in writing to share development data with Allarity Lytix and Oncoheroes Verrica on terms substantially similar to the terms of this Section 4.5.